CD154:CD11b blockade increases the frequency and number of antigen-specific CD8+ T cells during murine EBV infection, promotes the differentiation of MPECs, and promotes the production of the pro-survival cytokine IL-2. This evidence concerns the gene IL2 and Epstein-Barr virus infection.